PATH Program

Medical devices and health technologies

PATH's medical devices and health technologies program leads the vanguard in translating innovative ideas into breakthrough health solutions. We accelerate access to affordable, appropriate health solutions to protect and treat the communities that need them most.

Read more

Contact

What we do

Advancing critical health technologies

All too often, existing medical devices and health technologies are inaccessible because they are too expensive or impractical for use in under-resourced health settings. We respond to these challenges by developing and scaling devices and tools with the potential to address the diseases and health issues that disproportionately affect women and children in low-resource settings.

Innovations

What we do

Our global health impact

Together with our public- and private-sector partners, the Medical Devices and Health Technologies program has investigated hundreds of medical devices, health technologies, and tools and advanced the most promising and appropriate technologies into affordable commercial products for use in country health programs and global health campaigns, reaching billions of people.

See our impact
Focus areas
Health technologies for women and children

We advance medical devices and health technologies that address the primary causes of maternal, newborn, and child mortality and morbidity, and maximize public health impact by increasing availability and access to these innovations as part of integrated health systems.

Formulation technologies

We optimize, adapt, test, and validate emerging concepts, technologies, and product formats that optimize vaccine and pharmaceutical efficacy, stability, safety, and ease of use. We develop and qualify analytical assays to support development of stable vaccine and pharmaceutical products. Some examples include oral liquid formulations and sublingual and fast-dissolving tablets.

Packaging and delivery technologies

We identify and advance primary packaging and delivery innovations for vaccines and pharmaceuticals that have the potential to maximize efficacy, increase access, and reduce costs. This improves the safety, acceptability, and effectiveness of immunization and drug delivery.

Supply systems and equipment

We advance supply systems and equipment, policies, and programs to help to store, monitor, and transport vaccines at appropriate temperatures across the supply chain. This work builds stronger immunization supply and logistics systems to reach every child.

Latest news
Journals and resources

Meet the team

  1. Courtney Jarrahian

    Global Program Leader

  2. Emily Jeffers

    Director of Finance and Administration

  3. Dr. Manjari Lal

    Portfolio Leader: Formulation Technologies

  4. Dr. Patricia Coffey

    Portfolio Leader: Health Technologies for Women and Children

  5. Joanie Robertson

    Portfolio Leader: Supply Systems and Equipment

  6. Jessica Mistilis

    Portfolio Leader: Packaging and Delivery Technologies

  7. Steven Diesburg

    Product Development Engineering Lead

  8. Dr. Mercy Mvundura

    Technical Advisor Health Economics

  9. Rachel Hammack

    Communications Manager

  10. Brian Taliesin

    Global Director, Living Labs, Center of Digital and Data Excellence

  11. Dr. Jessica White

    Evaluation and Research Laboratory Lead

  12. Betsy Wilskie

    Procurement and Supply Technical Assistance Lead

Related articles

Read our latest

67 Article s
  1. PATH Product Development Engineer Erin Rowand prepares a freeze-preventive vaccine carrier for testing in PATH’s environmental test chambers. Photo: PATH.
    July 26, 2022

    Breakthrough vaccine carrier solves an invisible challenge to vaccine potency

    Freeze-preventive vaccine carriers ensure vaccines stay cold enough without freezing—especially critical when transporting vaccines to remote areas.
  2. IMG_3554.JPG
    January 13, 2022

    Celebrating innovation, design, and impact at Living Labs Open Day

    “We aim to accelerate health innovations to design solutions that have a high impact in service delivery and anticipated higher success rate. There is a need to move from a place of merely creating solutions and imposing them on the people who use them to a place where solutions are co-created collectively with the users.” — Dr. Joseph Kayaya, lead product manager at PATH Living Labs
  3. Examples of Autodisable AD syringes Photo. PATH..jpg
    November 22, 2021

    The syringe shortage, explained

    As COVID-19 vaccines roll out, low- and middle-income countries are facing a massive syringe shortage. PATH experts unpack the causes and implications.
  4. Sharps disposal.jpg
    October 28, 2021

    Does the world have the tools to inoculate billions?

    COVID-19 vaccine rollouts have highlighted the critical role of autodisable syringes, sharps boxes, and other immunization tools.
  5. A PATH-facilitated diagnostic training in India.
    July 29, 2021

    Decentralizing testing for COVID-19 and beyond

    Testing is a key pillar of India’s COVID-19 response. But record daily cases and infections have overburdened its testing systems, prompting the need for a new approach.
  6. Lebowakgomo, Limpopo, South Africa -04262020 - Community Healthcare Workers conduct door to door screening for covid-19 in South Africa in a bid to minimise the spread of the virus. By Mukurukuru Media
    July 1, 2021

    Africa’s third wave is killing thousands and the world is not paying attention

    In some African countries the death rate has tripled in a week.
Previous
Next

Co-creating solutions

Living Labs

Read More